Shoreline Medical Addiction Treatment

09/26/2025

🌿 New guidelines caution that using cannabis during pregnancy or breastfeeding can increase risks like preterm birth, low birth weight, and developmental delays. With ma*****na becoming more common and accessible, more people are using it during pregnancy and breastfeeding. The good news? Talking openly with your doctor can help you find safe, supportive options for a healthy pregnancy and baby. 👶✨

ACOG uses cookies, pixels and similar technologies to personalize your website experience. By clicking “continue” or continuing to use our site, you agree to our Privacy Policy.

09/24/2025

✨ New Research Highlights ✨
Studies show that reducing alcohol use—even without complete abstinence—has powerful benefits:
✅ Lower risk of developing substance use disorders and other medical or psychiatric conditions
✅ Fewer alcohol-related problems, cravings, and health care costs
✅ Better day-to-day functioning and improved quality of life📊 Most participants in clinical trials were able to cut back successfully, and reductions achieved with active medications were as strong—or stronger—than other treatment goals.🌟 Bottom line: Every step toward reducing drinking makes a real difference. ✨ New Research Highlights ✨
Studies show that reducing alcohol use—even without complete abstinence—has powerful benefits:
✅ Lower risk of developing substance use disorders and other medical or psychiatric conditions
✅ Fewer alcohol-related problems, cravings, and health care costs
✅ Better day-to-day functioning and improved quality of life📊 Most participants in clinical trials were able to cut back successfully, and reductions achieved with active medications were as strong—or stronger—than other treatment goals.🌟 Bottom line: Every step toward reducing drinking makes a real difference.

Read the article from JAMA Psychiatry:

This narrative review examines the use of reductions in World Health Organization (WHO) risk drinking levels as an end point in pharmacotherapy trials for people with alcohol use disorder.

09/22/2025

Keep pushing forward, for the road ahead holds the promise of new achievements and the fulfillment of your ambitions.

09/19/2025

Accountability Builds Trust. 🔄💙

Our Soberlink Remote Alcohol Monitoring System helps rebuild trust and provide peace of mind. Whether for personal accountability, family reassurance, or legal requirements, Soberlink offers real-time results and easy-to-use technology.

Sobriety is a journey—stay on track with a system designed to support you every step of the way. Ready to take control?

📲 Learn more today!

https://buff.ly/dd1JkRq

09/17/2025

⚠️ A New Challenge in the Opioid Crisis ⚠️

Alongside fentanyl, another drug is making the overdose crisis even more dangerous: medetomidine, also known as “dex.”

🔹 Medetomidine is a powerful animal sedative, not approved for human use.
🔹 When mixed with fentanyl, it slows breathing and heart rate even further, making overdoses harder to reverse with naloxone.
🔹 This combination is now being found in the drug supply in the U.S., adding a new layer of risk for people who use opioids.

💡 What this means:
• Overdoses may look different — people can appear sedated for longer periods.
• Naloxone still helps with fentanyl, but may not fully reverse the sedative effects.
• Medical care is critical in suspected overdoses.

At Shoreline MAT, we continue to advocate for safer communities, harm reduction, and access to evidence-based treatment. 🌊💙

Medetomidine, or dex, is emerging as a dangerous xylazine replacement in illicit fentanyl, complicating overdose response and posing severe withdrawal risks.

09/15/2025

💊 Treatment Saves Lives — Even Behind Bars 💊
New research shows that people who receive medications for opioid use disorder (MOUD) while incarcerated have:
✨ Better recovery after release
✨ Lower risk of overdose & death
✨ Lower chances of going back to jail➡️ 60% started treatment within 30 days of release
➡️ 58% stayed on treatment at 6 months
➡️ 52% lower risk of fatal overdose🌊 At Shoreline MAT, we believe recovery should be possible everywhere.

In 2019, seven county correctional facilities (jails) in Massachusetts initiated pilot programs to provide all Food and Drug Administration–approved medications for opioid use disorder (MOUD). This...

09/12/2025

🚨 New research shows patients are still facing challenges filling their buprenorphine prescriptions at pharmacies.
These barriers not only cause frustration—they can disrupt recovery and create unnecessary setbacks. At Shoreline MAT, we believe every patient deserves timely, stigma-free access to treatment. 💙

📢 Let’s keep pushing for better awareness, education, and access—because recovery shouldn’t depend on pharmacy hurdles.

Less than 40% of pharmacies in the United States are able to fill a prescription for the opioid addiction medication buprenorphine, according to a new study.

07/22/2025

❤️

06/30/2025

Advocacy changes lives. By speaking up for better policies, supporting treatment access, or even just sharing accurate information, you’re helping to change the way we treat addiction.

Recovery is everyone’s business.

06/27/2025

This weekend, reach out to someone in recovery—or someone
who might be struggling. A quick check-in could make their day.

Let’s to recovery together.

06/25/2025

Let’s hear from you: What support meant the most during your recovery—or someone else’s? A kind word? A flexible job? A second chance?

Comment below.👇

06/23/2025

From peer support to medical treatment, there are so many resources in our community to help with addiction recovery. Not sure where to start? Check out a great webpage from Volusia Recovery Alliance: https://buff.ly/9uWMRoE

And contact us at Shoreline Medical—we’re here to help. 💬